Genetic dissection of Cardiac Conduction System homeostasis and regeneration
Genetic dissection of Cardiac Conduction System homeostasis and regeneration
批准号:
9740018
负责人:
Jun Wang
金额:
$36.62万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-15 至 2022-12-31
关键词:
AblationAdultAgingAntibodiesArrhythmiaBioinformaticsBiological AssayCalciumCalcium ionCardiac Function StudyCardiac MyocytesCardiac ablationCardiac conduction systemCardiac developmentCardiovascular DiseasesCause of DeathCell DeathCell physiologyCellsCessation of lifeChIP-seqDataDefectDevelopmentDissectionDrug toxicityElectrophysiology (science)Expression ProfilingFibrosisFunctional disorderGene ExpressionGenesGeneticGenetic TranscriptionGoalsHeartHeart ContractilitiesHeart DiseasesHistologyHomeostasisHumanHypertrophyImmunofluorescence ImmunologicImpairmentIn VitroInfarctionInheritedInjuryKnock-inLuciferasesMethodsMicroRNAsMolecularMorbidity - disease rateMusMutationMyocardial InfarctionMyocardial IschemiaMyocardial dysfunctionNatural regenerationOrgan SizePathologicPathway interactionsPatientsPeriodicityPhosphotransferasesRNA SequencesRegulationReporterRepressionRoleRyR2Ryanodine Receptor Calcium Release ChannelSamplingSignal TransductionSyndromeTechniquesTestingTissuesToxic effectdiphtheria toxin fragment Again of functiongenome-wideheart functionheart rhythmin vivoinsightmortalitynoveloverexpressiontargeted treatment
中文摘要
摘要
心脏传导系统动态平衡与再生的遗传学解剖
心脏传导系统(CCS)是启动和维持有规律的有节奏的心跳所必需的。
CCS缺陷通常会引起心律失常,这是全球发病率和死亡率的主要原因。二氧化碳捕获
由于药物中毒或心肌梗死等疾病,功能障碍可能是遗传的或后天的。它是
迫切需要阐明CCS动态平衡的分子机制以促进
心脏疗法。重要的是,由于大量的技术问题,人们对这些机制知之甚少。
挑战。河马信号,一个关键的器官大小控制途径,抑制心肌细胞的增殖和
再生。然而,河马信号在CCS中的作用尚不清楚。在这里我们将确定河马是否
信号调节CCS的动态平衡。此外,我们将确定河马信号的监管机构和目标
CCS。我们的初步观察显示,CCS中河马信号的中断导致心脏
小鼠的心律失常,提示河马信号在CCS动态平衡中起重要作用。值得注意的是,删除
河马信号挽救了CCS细胞消融后的心律和功能,提示河马的抑制作用
信令保护容器服务免受损坏。此外,我们确定了候选的microRNA调节器和
河马信号的下游目标。在此,我们建议研究其功能和分子调控。
河马在CCS中的信令机制通过以下具体目的:1)定义河马信令
在CCS动态平衡中的作用,并阐明抑制Hippo信号保护
CCS来自损害,2)识别CCS中河马信号的上游microRNA调节因子,以及3)识别
调节CCS功能的河马途径下游靶点。
英文摘要
Abstract
Genetic dissection of Cardiac Conduction System homeostasis and regeneration
The cardiac conduction system (CCS) is required for initiating and maintaining regular rhythmic heartbeats.
CCS defects commonly give rise to arrhythmia, a leading cause of morbidity and death worldwide. CCS
dysfunction can be inherited or acquired due to conditions such as drug toxicity or myocardial infarction. It is
imperative to elucidate the molecular mechanisms underlying CCS homeostasis to facilitate development of
cardiac therapies. Importantly, these mechanisms are poorly understood owing to numerous technical
challenges. Hippo signaling, a pivotal organ size control pathway, inhibits cardiomyocyte proliferation and
regeneration. However, the role of Hippo signaling in the CCS is unclear. Here we will determine whether Hippo
signaling regulates CCS homeostasis. Additionally, we will identify regulators and targets of Hippo signaling in
the CCS. Our preliminary observations revealed that disruption of Hippo signaling in the CCS caused cardiac
arrhythmias in mice, suggesting an important role of Hippo signaling in CCS homeostasis. Notably, deletion of
Hippo signaling rescued cardiac rhythm and function after CCS cell ablation, suggesting that repression of Hippo
signaling protects the CCS from damage. In addition, we identified candidate microRNA regulators and
downstream targets of Hippo signaling. Here we propose to investigate the function and molecular regulatory
mechanism of Hippo signaling in the CCS through in the following specific aims: 1) To define Hippo signaling
function in CCS homeostasis and elucidate the mechanism by which repression of Hippo signaling protects the
CCS from damage, 2) Identify upstream microRNA regulators of Hippo signaling in the CCS, and 3) Identify
downstream targets of the Hippo pathway that modulate CCS function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Striatal ensemble plasticity in alcohol use disorder
-
批准号:10734890
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2023
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10457835
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
High-Resolution Spatial MIST Technology for Functional Proteomic Study of Neuroinflammation in Alzheimer's Disease
-
批准号:10343115
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Repurposing of Maraviroc for the treatment of neuropathic pain
-
批准号:10586296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10364861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
NanoDiagnotic Technology I-Corps Training
-
批准号:10541690
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10543633
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10693823
-
项目类别:
-
资助金额:$73.01万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10653682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10191875
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10443877
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10282122
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Development of an integrated smartphone/resistive nanosensor for onsite biomonitoring of exposure to pesticides
-
批准号:10255622
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Single-Cell Functional Proteomics Study of Neurodegeneration in Alzheimer's Disease
-
批准号:10191268
-
项目类别:
-
资助金额:$43.86万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10599264
-
项目类别:
-
资助金额:$33.33万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10513411
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10190746
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10543627
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10454230
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10693144
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
海外基金